United Pharm - Asset Resilience Ratio

Latest as of March 2026: 22.90%

United Pharm (033270) has an Asset Resilience Ratio of 22.90% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See United Pharm short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩128.97 Billion

≈ $87.40 Million USD Cash + Short-term Investments

Total Assets

₩563.13 Billion

≈ $381.63 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how United Pharm's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see United Pharm asset portfolio.

Liquid Assets Composition Over Time

This chart breaks down United Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore United Pharm long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩128.97 Billion	22.9%
Total Liquid Assets	₩128.97 Billion	22.90%

Asset Resilience Insights

Good Liquidity Position: United Pharm maintains a healthy 22.90% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

United Pharm Industry Peers by Asset Resilience Ratio

Compare United Pharm's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Dr. Reddy's Laboratories Limited F:RDDA	Drug Manufacturers - Specialty & Generic	11.36%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Apeloa Pharmaceutical Co Ltd SHE:000739	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.35%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	0.66%

Annual Asset Resilience Ratio for United Pharm (2011–2025)

The table below shows the annual Asset Resilience Ratio data for United Pharm.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.48%	₩116.77 Billion ≈ $79.13 Million	₩519.49 Billion ≈ $352.05 Million	+1.67pp
2024-12-31	20.81%	₩98.61 Billion ≈ $66.83 Million	₩473.93 Billion ≈ $321.17 Million	-6.31pp
2023-12-31	27.12%	₩127.14 Billion ≈ $86.16 Million	₩468.86 Billion ≈ $317.74 Million	-0.58pp
2022-12-31	27.70%	₩115.74 Billion ≈ $78.43 Million	₩417.89 Billion ≈ $283.20 Million	+11.28pp
2021-12-31	16.41%	₩62.37 Billion ≈ $42.27 Million	₩380.03 Billion ≈ $257.54 Million	+1.20pp
2020-12-31	15.21%	₩53.76 Billion ≈ $36.44 Million	₩353.43 Billion ≈ $239.52 Million	+3.71pp
2019-12-31	11.50%	₩38.09 Billion ≈ $25.81 Million	₩331.24 Billion ≈ $224.48 Million	-0.82pp
2018-12-31	12.32%	₩37.19 Billion ≈ $25.20 Million	₩301.95 Billion ≈ $204.63 Million	+0.09pp
2017-12-31	12.23%	₩32.51 Billion ≈ $22.03 Million	₩265.80 Billion ≈ $180.13 Million	+1.69pp
2016-12-31	10.54%	₩24.70 Billion ≈ $16.74 Million	₩234.22 Billion ≈ $158.73 Million	+5.15pp
2014-12-31	5.40%	₩11.72 Billion ≈ $7.94 Million	₩217.10 Billion ≈ $147.13 Million	+5.08pp
2013-12-31	0.32%	₩615.09 Million ≈ $416.84K	₩193.54 Billion ≈ $131.16 Million	-4.67pp
2012-12-31	4.99%	₩9.36 Billion ≈ $6.34 Million	₩187.58 Billion ≈ $127.12 Million	+4.76pp
2011-12-31	0.23%	₩384.56 Million ≈ $260.61K	₩170.09 Billion ≈ $115.26 Million	--

pp = percentage points

About United Pharm

KO:033270 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$178.42 Million

₩263.27 Billion KRW

Market Cap Rank

#17111 Global

#670 in Korea

Share Price

₩18230.00

Change (1 day)

-1.46%

52-Week Range

₩16600.00 - ₩21400.00

All Time High

₩95918.11